Literature DB >> 19963238

"Complete transurethral resection of bladder tumor": are the guidelines being followed?

Kishore T Adiyat1, Devendar Katkoori, Cynthia T Soloway, Rosely De los Santos, Murugesan Manoharan, Mark S Soloway.   

Abstract

OBJECTIVES: To determine how often complete eradication of all visible tumors during transurethral resection of bladder tumor (TURBT) is accomplished in a referral setting. The American Urological Association guidelines recommend complete eradication whenever possible.
METHODS: We retrospectively reviewed the records of patients who underwent a second TURBT within 4 weeks of being referred to us. Relevant data such as residual tumor location, number, stage, and grade were collected and analyzed. Patients with muscle invasive tumor or known incomplete resection were excluded.
RESULTS: Forty-seven patients met the inclusion criteria. Mean age was 75 years. In the initial TURBT, 35 (75%) had a high grade tumor and 12 (25%) had low grade tumors. Twenty-four (52%) were Ta and 23 (48%) were T1 tumors. Of the 47 patients who satisfied the criteria, 33 (70%) had an initial incomplete resection. Of these, 10 (30%) had macroscopic residual tumor at the resection site. Twenty-three (70%) had at least 1 unresected tumor away from the previous resection site. There were 39 unresected or partially resected tumors. Thirteen (33%) tumors were located in the anterior wall, 12 (31%) in the posterior wall and trigone, 10 (26%) in the lateral wall, 3 (7.5%) in the dome, and 1 (2.5%) in the prostatic urethra.
CONCLUSIONS: Although TURBT is a commonly performed operation, in this selected series, the incidence of unresected and gross residual tumor after initial TURBT is high. This indicates a need to emphasize the guidelines for a complete resection and to emphasize the use of a proper technique in this commonly performed urological procedure. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19963238     DOI: 10.1016/j.urology.2009.08.082

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.

Authors:  Stefania Zamboni; Marco Moschini; Andrea Gallina; Renzo Colombo; Francesco Montorsi; Alberto Briganti; Andrea Salonia; Alessandro Antonelli; Claudio Simeone; Sandra Belotti; Luca Cristinelli; Agostino Mattei; Philipp Baumeister
Journal:  World J Urol       Date:  2019-03-25       Impact factor: 4.226

2.  [Therapy of low-grade nonmuscle-invasive bladder cancer].

Authors:  P J Olbert; C H Ohlmann; C Schwentner
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

Review 3.  What is new in non-muscle-invasive bladder cancer in 2016?

Authors:  Ashish M Kamat; Murat Bağcıoğlu; Emre Huri
Journal:  Turk J Urol       Date:  2017-03-01

Review 4.  Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies.

Authors:  Daniel Zainfeld; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

5.  Kinematic and experimental investigation of manual resection tools for transurethral bladder tumor resection.

Authors:  Nima Sarli; Tracy Marien; Christopher R Mitchell; Giuseppe Del Giudice; Mary S Dietrich; S Duke Herrell; Nabil Simaan
Journal:  Int J Med Robot       Date:  2016-10-20       Impact factor: 2.547

Review 6.  Approaching the optimal transurethral resection of a bladder tumor.

Authors:  Michael Jurewicz; Mark S Soloway
Journal:  Turk J Urol       Date:  2014-06

7.  Preliminary Porcine In Vivo Evaluation of a Telerobotic System for Transurethral Bladder Tumor Resection and Surveillance.

Authors:  Nima Sarli; Giuseppe Del Giudice; Smita De; Mary S Dietrich; Stanley Duke Herrell; Nabil Simaan
Journal:  J Endourol       Date:  2018-06       Impact factor: 2.942

8.  A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor.

Authors:  Christopher Anderson; Ryan Weber; Darshan Patel; William Lowrance; Adam Mellis; Michael Cookson; Maximilian Lang; Daniel Barocas; Sam Chang; Elizabeth Newberger; Jeffrey S Montgomery; Alon Z Weizer; Cheryl T Lee; Bruce R Kava; Max Jackson; Anoop Meraney; Daniel Sjoberg; Bernard Bochner; Guido Dalbagni; Machele Donat; Harry Herr
Journal:  J Urol       Date:  2016-04-01       Impact factor: 7.450

Review 9.  ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer.

Authors:  Leonardo L Monteiro; J Alfred Witjes; Piyush K Agarwal; Christopher B Anderson; Trinity J Bivalacqua; Bernard H Bochner; Joost L Boormans; Sam S Chang; Jose L Domínguez-Escrig; James M McKiernan; Colin Dinney; Guilherme Godoy; Girish S Kulkarni; Paramananthan Mariappan; Michael A O'Donnell; Cyrill A Rentsch; Jay B Shah; Eduardo Solsona; Robert S Svatek; Antoine G van der Heijden; F Johannes P van Valenberg; Wassim Kassouf
Journal:  World J Urol       Date:  2018-08-14       Impact factor: 4.226

10.  Intravesical therapy for urothelial carcinoma of the bladder.

Authors:  M Manoharan
Journal:  Indian J Urol       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.